GTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: Subgroup analysis of the prospective randomized CHARTWEL trial
Authors:
- Ala YarominaAYAla Yaromina
- Steffen AppoldSASteffen Appold
- Daniel ZipsDZDaniel Zips
- Carsten ReiffenstuhlCRCarsten Reiffenstuhl
- Andreas SchreiberASAndreas Schreiber
- Howard D. ThamesHTHoward D. Thames
- Mechthild KrauseMKMechthild Krause
- Michael BaumannMBMichael Baumann
- 1 March 2013
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 106 (3) , 299-304
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Krebshilfe (T1/Ba1, #70-2206)
- DAAD
- Egyptian Ministry of Higher Education
This publication has 29 references indexed in Scilit:
- The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: A prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05)Radiotherapy and Oncology, 2013
- Hyperfractionated or Accelerated Radiotherapy in Lung Cancer: An Individual Patient Data Meta-AnalysisJournal of Clinical Oncology, 2012
- Cancer stem cells at the crossroads of current cancer therapy failures—Radiation oncology perspectiveSeminars in Cancer Biology, 2010
- Development and External Validation of Prognostic Model for 2-Year Survival of Non–Small-Cell Lung Cancer Patients Treated With ChemoradiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Exploring the role of cancer stem cells in radioresistanceNature Reviews Cancer, 2008
- High Radiation Dose May Reduce the Negative Effect of Large Gross Tumor Volume in Patients With Medically Inoperable Early-Stage Non–Small Cell Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapyLung Cancer, 2006
- Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trialRadiotherapy and Oncology, 1999
- Tumor Volume and Local Control in Primary Radiotherapy of Nasopharyngeal CarcinomaActa Oncologica, 1999
- An ‘Incomplete-repair’ Model for Survival after Fractionated and Continuous IrradiationsInternational Journal of Radiation Biology, 1985